1.
Sustained reduction of intraocular pressure in humans with the calcium channel blocker verapamil.
Abelson M B, Gilbert C M, Smith L M
Am J OphthalmolFeb 19880 citationsClinical Trial
Topical verapamil significantly lowered intraocular pressure in ocular hypertensive patients for up to ten hours, suggesting its potential as a new glaucoma treatment.